CSB Tri-Axis Dominant-Primary Series I-PR

Mentha × piperita

Peppermint

Tier ICSB Tri-Axis Dominant-Primary Series

Target Trait

1.1×

fold-change

Cooling-dominant tri-axis S+B modulated fold-change

Technical Specifications

SKU

SS-F-M3-02178

Genomic Edits

GC Content

44.9%

Construct Length

4,099 bp

Promoter System

Ubiquitin / T7

Expression System

Protoplast PEG-fusion

Host Strain

PEG-mediated

Receptor Target

TRPM8 + TAS1R2/TAS1R3 + TAS2R38 (suppression)

IFI Score

110

Pathway Edits

TRPM8 pathway primary gene cluster for cooling (IFI-C) tri-axis component
TAS1R2/TAS1R3 pathway primary gene cluster for sweet (IFI-S) tri-axis component
TAS2R38 (suppression) pathway primary gene cluster for bitter-attenuation (IFI-B) tri-axis component
Tri-axis metabolic flux partitioning hub for concurrent CSB pathway operation
Cross-pathway regulatory circuit for cooling-dominant CSB triple-axis expression
Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPM8, TAS1R2/TAS1R3, and TAS2R38 (suppression) pathways simultaneously engineeredCooling-dominant tri-axis expression strategy (CSB) with cross-pathway flux managementPEG-mediated co-transfection of axis constructs for rapid phenotypic screening of multi-axis combinations

IFI Subscale Profile

IFI Profile

IFI-S

—

IFI-U

—

IFI-B

—

IFI-K

—

IFI-C

—

IFI-P

—

IFI-A

—

IFI-F

—

Use Case

Tier I CSB triple-axis construct for advanced multi-modal sensory architecture combining cooling, sweet, and bitter-attenuation axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$299 · Tier I License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?

Back to Multi-Axis · IFI-M All Modalities